This randomized controlled clinical trial aims to compare the taste acceptance and clinical effectiveness of hyaluronic mouthwash and chlorhexidine mouthwash in children with plaque-induced gingivitis. Clinical outcomes will be assessed using gingival and plaque indices, while taste acceptance will be evaluated using a validated hedonic scale. The findings may help identify a mouthwash that is both effective and acceptable to children, thereby improving adherence to oral hygiene practices.
Children aged from 8-12 years of both sexes.
Children with a history of bleeding on brushing typical signs and symptoms of gingivitis.
Healthy child (ASA I).
Eruption of upper and lower permanent central and lateral incisors.
Children -allergic to Chlorhexidine or Hyaluronic acid.
Children with special health care needs or having a history of serious systemic disease that may affect the gingival health.
Use of Systemic NSAIDs, steroids, or antibiotics within a month before the study.
Children undergoing orthodontic treatment or having an intra-oral prosthesis.
Parallel
Hyaluronic Acid mouthwash
DrugQ-Afta®, CIRA Pharma, Egypt
Chlorohexidine 0.12% mouthwash
DrugHexitol®, 0.12% chlorhexidine gluconate; Arab Drug Company
Plaque index
Plaque index will be measured by Löe \& Silness plaque index
Gingival index
Gingival health will be measured by Löe \& Silness gingival index
Taste acceptance
Taste acceptance will be assessed using a visual analog scale (VAS) of faces, rated from 1 to 5, where 1 represents very bad taste, and 5 represents very good taste
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
